Breast Cancer: Advances in ESR1 Inhibitor Therapy
In the evolving landscape of breast cancer treatment, ESR1 inhibitors represent a significant advancement against therapy-resistant cases linked to estrogen receptor mutations. From breakthrough drugs like camizestrant and elacestrant to novel detection methods, these therapies are transforming management strategies, offering personalized, effective solutions for patients battling hormone receptor-positive breast cancer. Exploring ESR1 Inhibitors in Breast […]
3 minute read